Opioid Crisis Fallout: Supreme Court Blocks $6 Billion Purdue Pharma Deal Threatening Victim Payouts

Washington, DC – In a momentous decision, the Supreme Court smashed the extensive bankruptcy reorganization of Purdue Pharma, the opioid manufacturer, ruling that the settlement improperly shielded the Sackler family. This ruling puts at risk billions of dollars earmarked for victims of the opioid crisis. The 5-4 vote concluded that the bankruptcy court overstepped its bounds by absolving the Sackler family from legal liabilities related to the misdeeds of Purdue Pharma. The arrangement included an …

Read more

Alaska Opioid Crisis: Fatal Overdoses Hit Record High – What You Need to Know to Save Lives

Anchorage, Alaska set a somber new record as it reported the highest number of deaths from opioid overdoses in 2023 than in any previous year, according to the Alaska Department of Health. The state also experienced the largest year-to-year increase in overdose deaths in the nation, based on preliminary data from the Centers for Disease Control and Prevention. The spike in deaths in Alaska was primarily attributed to the prevalence of fentanyl, a potent synthetic …

Read more

**Opioid Crisis Spikes in DC: Over 500 Deaths Last Year – Is the Capitol City Doomed?**

Washington, D.C. – Over 500 residents in the District succumbed to opioid overdoses last year, according to recent data, marking a troubling new record in the city’s ongoing battle against this escalating crisis. The stark reality of the situation was revealed in a March report from D.C.’s chief medical examiner, highlighting a 12% increase in opioid-related deaths to a total of 518 fatalities, continuing a concerning trend that has persisted for five consecutive years since …

Read more

**Alcohol Use Disorder Breakthrough: Targeting Kappa Opioid Receptors Reduces Drinking in Animal Models**

Boca Raton, Florida – A recent study conducted at the Scripps Research Institute has unveiled promising results in the treatment of alcohol use disorder (AUD). Researchers have identified a compound, LY2444296, that targets the kappa opioid receptor, showing significant potential in reducing alcohol consumption in animal models of alcohol dependence. This breakthrough offers hope for individuals struggling with AUD by honing in on the brain’s KOP system, known to play a crucial role in addiction …

Read more